35 related articles for article (PubMed ID: 32830201)
1. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.
Liu J; Prager-van der Smissen WJC; Collée JM; Bolla MK; Wang Q; Michailidou K; Dennis J; Ahearn TU; Aittomäki K; Ambrosone CB; Andrulis IL; Anton-Culver H; Antonenkova NN; Arndt V; Arnold N; Aronson KJ; Augustinsson A; Auvinen P; Becher H; Beckmann MW; Behrens S; Bermisheva M; Bernstein L; Bogdanova NV; Bogdanova-Markov N; Bojesen SE; Brauch H; Brenner H; Briceno I; Brucker SY; Brüning T; Burwinkel B; Cai Q; Cai H; Campa D; Canzian F; Castelao JE; Chang-Claude J; Chanock SJ; Choi JY; Christiaens M; Clarke CL; ; Couch FJ; Czene K; Daly MB; Devilee P; Dos-Santos-Silva I; Dwek M; Eccles DM; Eliassen AH; Fasching PA; Figueroa J; Flyger H; Fritschi L; Gago-Dominguez M; Gapstur SM; García-Closas M; García-Sáenz JA; Gaudet MM; Giles GG; Goldberg MS; Goldgar DE; Guénel P; Haiman CA; Håkansson N; Hall P; Harrington PA; Hart SN; Hartman M; Hillemanns P; Hopper JL; Hou MF; Hunter DJ; Huo D; ; Ito H; Iwasaki M; Jakimovska M; Jakubowska A; John EM; Kaaks R; Kang D; Keeman R; Khusnutdinova E; Kim SW; Kraft P; Kristensen VN; Kurian AW; Le Marchand L; Li J; Lindblom A; Lophatananon A; Luben RN; Lubiński J; Mannermaa A; Manoochehri M; Manoukian S; Margolin S; Mariapun S; Matsuo K; Maurer T; Mavroudis D; Meindl A; Menon U; Milne RL; Muir K; Mulligan AM; Neuhausen SL; Nevanlinna H; Offit K; Olopade OI; Olson JE; Olsson H; Orr N; Park SK; Peterlongo P; Peto J; Plaseska-Karanfilska D; Presneau N; Rack B; Rau-Murthy R; Rennert G; Rennert HS; Rhenius V; Romero A; Ruebner M; Saloustros E; Schmutzler RK; Schneeweiss A; Scott C; Shah M; Shen CY; Shu XO; Simard J; Sohn C; Southey MC; Spinelli JJ; Tamimi RM; Tapper WJ; Teo SH; Terry MB; Torres D; Truong T; Untch M; Vachon CM; van Asperen CJ; Wolk A; Yamaji T; Zheng W; Ziogas A; Ziv E; Torres-Mejía G; Dörk T; Swerdlow AJ; Hamann U; Schmidt MK; Dunning AM; Pharoah PDP; Easton DF; Hooning MJ; Martens JWM; Hollestelle A
Sci Rep; 2020 Jun; 10(1):9688. PubMed ID: 32546843
[TBL] [Abstract][Full Text] [Related]
2. Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank.
Papier K; Atkins JR; Tong TYN; Gaitskell K; Desai T; Ogamba CF; Parsaeian M; Reeves GK; Mills IG; Key TJ; Smith-Byrne K; Travis RC
Nat Commun; 2024 May; 15(1):4010. PubMed ID: 38750076
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Germline DNA Repair Gene and
Boyle JL; Hahn AW; Kapron AL; Kohlmann W; Greenberg SE; Parnell TJ; Teerlink CC; Maughan BL; Feng BJ; Cannon-Albright L; Agarwal N; Cooney KA
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923906
[TBL] [Abstract][Full Text] [Related]
4. Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.
Shi Z; Platz EA; Wei J; Na R; Fantus RJ; Wang CH; Eggener SE; Hulick PJ; Duggan D; Zheng SL; Cooney KA; Isaacs WB; Helfand BT; Xu J
Eur Urol; 2021 Mar; 79(3):419-426. PubMed ID: 33257031
[TBL] [Abstract][Full Text] [Related]
5. The HOXB13 p.Gly84Glu variant observed in an extended five generation high-risk prostate cancer pedigree supports risk association for multiple cancer sites.
Cannon-Albright LA; Stevens J; Teerlink CC; Agarwal N
Cancer Epidemiol; 2020 Dec; 69():101834. PubMed ID: 33099213
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
Shi Z; Wei J; Na R; Resurreccion WK; Zheng SL; Hulick PJ; Helfand BT; Talamonti MS; Xu J
Int J Cancer; 2021 Apr; 148(7):1658-1664. PubMed ID: 33300603
[TBL] [Abstract][Full Text] [Related]
7. Are population level familial risks and germline genetics meeting each other?
Hemminki K; Li X; Försti A; Eng C
Hered Cancer Clin Pract; 2023 Mar; 21(1):3. PubMed ID: 36882784
[TBL] [Abstract][Full Text] [Related]
8. CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer.
Nyberg T; Brook MN; Ficorella L; Lee A; Dennis J; Yang X; Wilcox N; Dadaev T; Govindasami K; Lush M; Leslie G; Lophatananon A; Muir K; Bancroft E; Easton DF; Tischkowitz M; Kote-Jarai Z; Eeles R; Antoniou AC
J Clin Oncol; 2023 Feb; 41(5):1092-1104. PubMed ID: 36493335
[TBL] [Abstract][Full Text] [Related]
9. Precision intervention for prostate cancer: Re-evaluating who is at risk.
Papachristodoulou A; Abate-Shen C
Cancer Lett; 2022 Jul; 538():215709. PubMed ID: 35490919
[TBL] [Abstract][Full Text] [Related]
10. Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer.
Morgan R; Hunter K; Pandha HS
Int J Cancer; 2022 Jun; 150(12):1919-1932. PubMed ID: 35080776
[TBL] [Abstract][Full Text] [Related]
11. Updates on Molecular and Biochemical Development and Progression of Prostate Cancer.
Fahmy O; Alhakamy NA; Rizg WY; Bagalagel A; Alamoudi AJ; Aldawsari HM; Khateb AM; Eldakhakhny BM; Fahmy UA; Abdulaal WH; Fresta CG; Caruso G
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768647
[TBL] [Abstract][Full Text] [Related]
12. Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management.
Doan DK; Schmidt KT; Chau CH; Figg WD
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33947030
[TBL] [Abstract][Full Text] [Related]
13. Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention.
Vietri MT; D'Elia G; Caliendo G; Resse M; Casamassimi A; Passariello L; Albanese L; Cioffi M; Molinari AM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916521
[TBL] [Abstract][Full Text] [Related]
14. Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank.
Wei J; Shi Z; Na R; Wang CH; Resurreccion WK; Zheng SL; Hulick PJ; Cooney KA; Helfand BT; Isaacs WB; Xu J
Br J Cancer; 2020 Oct; 123(9):1356-1359. PubMed ID: 32830201
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Kote-Jarai Z; Mikropoulos C; Leongamornlert DA; Dadaev T; Tymrakiewicz M; Saunders EJ; Jones M; Jugurnauth-Little S; Govindasami K; Guy M; Hamdy FC; Donovan JL; Neal DE; Lane JA; Dearnaley D; Wilkinson RA; Sawyer EJ; Morgan A; Antoniou AC; Eeles RA;
Ann Oncol; 2015 Apr; 26(4):756-761. PubMed ID: 25595936
[TBL] [Abstract][Full Text] [Related]
16. A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men.
Lin X; Qu L; Chen Z; Xu C; Ye D; Shao Q; Wang X; Qi J; Chen Z; Zhou F; Wang M; Wang Z; He D; Wu D; Gao X; Yuan J; Wang G; Xu Y; Wang G; Dong P; Jiao Y; Yang J; Ou-Yang J; Jiang H; Zhu Y; Ren S; Zhang Z; Yin C; Wu Q; Zheng Y; Turner AR; Tao S; Na R; Ding Q; Lu D; Shi R; Sun J; Liu F; Zheng SL; Mo Z; Sun Y; Xu J
Prostate; 2013 Jan; 73(2):169-75. PubMed ID: 22718278
[TBL] [Abstract][Full Text] [Related]
17. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
[TBL] [Abstract][Full Text] [Related]
18. Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls.
Shang Z; Zhu S; Zhang H; Li L; Niu Y
Eur Urol; 2013 Jul; 64(1):173-6. PubMed ID: 23518396
[No Abstract] [Full Text] [Related]
19. Screening for familial and hereditary prostate cancer.
Lynch HT; Kosoko-Lasaki O; Leslie SW; Rendell M; Shaw T; Snyder C; D'Amico AV; Buxbaum S; Isaacs WB; Loeb S; Moul JW; Powell I
Int J Cancer; 2016 Jun; 138(11):2579-91. PubMed ID: 26638190
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
